Health Business – USAY 7 http://usay7.net/ Sat, 28 Aug 2021 00:24:32 +0000 en-US hourly 1 https://wordpress.org/?v=5.8 https://usay7.net/wp-content/uploads/2021/06/icon-150x150.png Health Business – USAY 7 http://usay7.net/ 32 32 Coronavirus: Westland Mayor Bruce Smith is fed up with hearing from health professionals about COVID-19 and wants business leaders to have a bigger say https://usay7.net/coronavirus-westland-mayor-bruce-smith-is-fed-up-with-hearing-from-health-professionals-about-covid-19-and-wants-business-leaders-to-have-a-bigger-say/ https://usay7.net/coronavirus-westland-mayor-bruce-smith-is-fed-up-with-hearing-from-health-professionals-about-covid-19-and-wants-business-leaders-to-have-a-bigger-say/#respond Sat, 28 Aug 2021 00:24:32 +0000 https://usay7.net/coronavirus-westland-mayor-bruce-smith-is-fed-up-with-hearing-from-health-professionals-about-covid-19-and-wants-business-leaders-to-have-a-bigger-say/ Before the highly contagious Delta variant of the virus was picked up earlier this month, New Zealand was one of only a few large economies that did not have community transmission of the virus, which has killed millions of people worldwide in the past 18 months. The elimination of the virus was a boost to […]]]>

Before the highly contagious Delta variant of the virus was picked up earlier this month, New Zealand was one of only a few large economies that did not have community transmission of the virus, which has killed millions of people worldwide in the past 18 months. The elimination of the virus was a boost to the economy, which rebounded much more than many expected, with unemployment quickly returning to pre-pandemic levels of 4 percent.

But Smith disagrees with epidemiologists that a strong health response is the best way to help the economy.

“I think the people who say that are all paid by the state. They get their wages every Thursday, it doesn’t make a big difference to them.

He complained that government economic aid was too focused on workers and not enough on business owners, despite the fact that numerous aid packages were available.

“While the subsidies for the employees worked very well, [employers are] the people who wake up every morning looking at their insurance payments, their lease payments, their car repayments, and all of their overheads. You are in a terrible position. I’m just terribly sorry for you. ”

He called for a “more balanced … mix between our economy and our health” and said the government’s response was “very much a health response” at the expense of the economy.

“The reality is that COVID is with us. It’s no different from polio in my grandparents’ days. The only way to fix this is to get vaccinated. I’ve encouraged everyone to get vaccinated, but even then it will still come. It will come from overseas. It’s part of our lives from now on and we have to adapt. “

]]>
https://usay7.net/coronavirus-westland-mayor-bruce-smith-is-fed-up-with-hearing-from-health-professionals-about-covid-19-and-wants-business-leaders-to-have-a-bigger-say/feed/ 0
Life Sciences Anti-Corruption Enforcement Trends To Watch For https://usay7.net/life-sciences-anti-corruption-enforcement-trends-to-watch-for/ https://usay7.net/life-sciences-anti-corruption-enforcement-trends-to-watch-for/#respond Tue, 24 Aug 2021 08:00:54 +0000 https://usay7.net/life-sciences-anti-corruption-enforcement-trends-to-watch-for/ The life sciences industry faces unique anti-corruption challenges associated with doing business in jurisdictions around the world with complex regulations and heavy public sector involvement in the delivery of health care services. Unlike many multinational corporations, life sciences companies have to deal with government involvement in just about every aspect of their business, from research […]]]>

The life sciences industry faces unique anti-corruption challenges associated with doing business in jurisdictions around the world with complex regulations and heavy public sector involvement in the delivery of health care services.

Unlike many multinational corporations, life sciences companies have to deal with government involvement in just about every aspect of their business, from research and development, through licensing and manufacturing, to distribution and final sales. Anti-corruption enforcement by US and foreign agencies is on the rise, and there are signs that this trend will continue.

US enforcement

The joint enforcement of the Foreign Corrupt Practices Act (FCPA) by the Department of Justice and the Securities and Exchange Commission remains the predominant enforcement mechanism of international anti-corruption law.

Between 2016 and 2020, US enforcement agencies filed almost 50% more FCPA-related lawsuits than in the previous five years. Life science companies remain a major US enforcement target, second only to the oil and gas industry.

As of 2011, the DOJ and SEC have filed enforcement actions against 23 life sciences companies that resulted in a total of $ 1.7 billion in fines, penalties, and levies.

Notable actions

The life sciences industry has seen a number of recent activities to enforce the FCPA. In 2020, the DOJ and SEC filed four lawsuits against U.S. and international pharmaceutical and medical device companies totaling $ 500 million in fines, penalties, and levies, and placed future reporting requirements.

In one of its largest lawsuits, Cardinal Health has resolved an SEC investigation into a Chinese subsidiary it acquired in 2010 in connection with improper payments to health care workers.

Cardinal’s subsidiary held marketing accounts for a European dermocosmetics company whose products it sold. That company ran the employees of Cardinal’s subsidiary, who used account funds to make payments to government health workers and employees of government-owned companies who influenced purchasing decisions. Cardinal agreed to pay $ 8.8 million to resolve alleged violations of the FCPA’s books and records and internal accounting controls.

In another measure, Herbalife Nutrition Ltd. Completed a joint DOJ and SEC investigation into book and file violations related to its operations in China between 2006 and 2016.

Herbalife employees paid the Chinese authorities with authority to approve licenses in 2006 and continued those payments over a 10-year period to encourage sales, a total of $ 25 million in entertainment and gifts to Chinese officials. Herbalife agreed to pay $ 123 million to resolve the investigation.

Corruption Risks in Life Sciences

Paying bribes to increase sales remains the greatest risk of corruption for life science companies. Because of government involvement in health care procurement in most parts of the world, health professionals responsible for procurement and prescribing medicines are typically considered “foreign officials” for the purposes of the FCPA.

Like the enforcement of the anti-kickback law in the US, payments to doctors and administrative staff who arrange for drugs to be bought or sold overseas may be subject to the FCPA’s bribery rules. Misrepresentation of payments to these individuals can affect the accounting rules of the FCPA, even if bribery cannot be proven.

Price controls and government approvals

Many countries regulate the sale of drugs through price controls, and virtually all of them require some regulatory approval before they can be sold domestically. The regulators who control drug sales prices and approvals vary by jurisdiction, but often involve people who are considered foreign officials. Interactions with and payments to these persons, including through third parties, must be carefully checked in order to avoid possible allegations of bribery.

Research abroad

Life science companies have dramatically increased the number of clinical trials conducted overseas in recent years, creating both an opportunity and an avenue to facilitate bribery. Clinical trials abroad are often overseen by local medical personnel who are often viewed as foreign officials. These individuals may face bribes in exchange for approval. The clinical trials themselves can also be an unnecessary effort with the true intention of marketing the company’s products to foreign officials.

High risk paths for corrupt payments

Life science companies have the usual suspects for potential bribery risks: excessive payments to consultants, brokers, distributors or third party agents; Gifts, hospitality, entertainment and travel expenses to politically exposed persons; and contributions to charities or companies affiliated with foreign officials.

Life science companies should also be aware of the potential for:

  • Falsely reported speaker fees and fees;
  • Counterfeit or overpriced storage contracts;
  • Excessive bills to customers or sales partners;
  • Joint ventures with companies affiliated with foreign officials;
  • Abused or falsified marketing and advertising spending;
  • Fake refund requests or cash distributions;
  • Excessive margins or discounts for distributors or channel partners; and
  • Research grants or official examiner costs.

Expectations for 2021 and beyond

We expect more resources and awareness of anti-corruption efforts from both the US and overseas in the foreseeable future. Life science companies can expect:

  • Expanded use of the FCPA’s accounting rules to penalize companies for suspected corrupt behavior when the DOJ is unable to raise allegations of bribery;
  • Increased use of non-FCPA mechanisms, including money laundering, postal fraud and wire transfer fraud, to combat corrupt behavior outside the scope of the FCPA;
  • Enhanced enforcement by non-US enforcement agencies, including increased cooperation and information sharing between those agencies;
  • Increased regulatory expectations regarding the design and effectiveness of corporate compliance programs and the implementation of robust internal corrective actions when misconduct is detected (or should have been detected); and
  • Increased whistleblower activity and higher whistleblower awards.

This column does not necessarily represent the opinion of the Bureau of National Affairs, Inc. or its owners.

Write for us: Guidelines for Authors

Information about the author

W. Warren Hamel, a partner at Venable, heads the firm’s investigations and commercial defense. He conducts internal investigations and defends private, corporate and non-profit clients in commercial and environmental criminal defense as well as in civil litigation.

Nick A. Mongelluzzo, an associate at Venable, helps clients enforce civil and criminal enforcement actions and advises on conducting internal company investigations.

]]>
https://usay7.net/life-sciences-anti-corruption-enforcement-trends-to-watch-for/feed/ 0
The latest: Schools in the capital of Florida require masks | Companies https://usay7.net/the-latest-schools-in-the-capital-of-florida-require-masks-companies/ https://usay7.net/the-latest-schools-in-the-capital-of-florida-require-masks-companies/#respond Sun, 22 Aug 2021 19:18:45 +0000 https://usay7.net/the-latest-schools-in-the-capital-of-florida-require-masks-companies/ TALLAHASSEE, Fla. – The headmaster in Florida’s capital announced Sunday that masks will be required for pre-kindergarten through eighth grade students, making it the seventh district to oppose Governor Ron DeSantis’ ban on such COVID-19 mandates opposes. Leon County Superintendent Rocky Hanna said the district has skyrocketed positive tests for the coronavirus since the school […]]]>

TALLAHASSEE, Fla. – The headmaster in Florida’s capital announced Sunday that masks will be required for pre-kindergarten through eighth grade students, making it the seventh district to oppose Governor Ron DeSantis’ ban on such COVID-19 mandates opposes.

Leon County Superintendent Rocky Hanna said the district has skyrocketed positive tests for the coronavirus since the school opened Aug. 11 in Tallahassee and its immediate suburbs. He said parents who do not want their elementary or middle school student to wear a mask must receive a signed note from their child’s doctor or psychologist by Friday.

Leon, which has 32,000 students, initially withdrew from such a mandate after DeSantis and Education Commissioner Richard Corcoran said that districts could only impose a mask mandate if parents could refuse their children themselves. They have threatened to cut funding from districts that impose stricter mandates and sanctions their elected officials.

Hanna said he was “fully for individual rights and freedoms and the rights of parents,” but that does not include the right to endanger the health of others.

“I don’t think masks are essential, but we know they make a difference. The vast majority of health professionals tell us they make a difference, “Hanna said in a statement broadcast on Facebook.

———

MORE ABOUT PANDEMIC:

– Bans or vaccines? 3 Pacific nations are trying divergent paths

– US mask, vaccination conflicts lead to violence and harassment

– Pandemic Fiction: Fall Books contain stories about the virus

– Rev. Jesse Jackson, Ms. Jacqueline, about COVID. taken to the hospital

– Hurricane Henri thwarted Central Park concert celebrating recovery from NYC virus

———

You can find more AP coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/hub/coronavirus-vaccine

———

HERE STILL HAPPEN:

WASHINGTON – U.S. surgeon Gen. Vivek Murthy says he wouldn’t be surprised if the Food and Drug Administration’s full approval of Pfizer’s COVID-19 vaccine comes soon, and he expects this to spur more vaccine mandates from schools and businesses will.

Murthy said Sunday that he did not want to pre-empt the FDA’s announcement but did not argue that it could happen this week. He cited a wealth of data showing that Pfizer’s two-dose therapy is safe and effective.

The vaccine is currently marketed under emergency FDA clearance. Murthy said he believes that once the agency completes its full review and approves it, more Americans will be convinced to take the pictures.

He also expected more vaccine requirements, including for teachers and staff, and described mandates as a “sensible” measure to create a safe environment for children and others.

Murthy said that with the highly transmissible Delta variant, “We must take every step we can” when health and wellbeing are “at stake”.

He has appeared on CNN’s State of the Union, ABC’s This Week and Fox News Sunday.

———

AUSTIN, Texas – Texas Governor Greg Abbott says he tested negative for COVID-19 just four days after testing positive.

“I was told my infection was short and mild because of the vaccination I received,” Abbott said in a video clip posted on his Twitter account on Saturday. “So I encourage others who have not yet received the vaccination to consider getting one.”

When the Republican governor announced Tuesday that he had tested positive for the virus, his office said he was in good health and had no symptoms. Abbott said Saturday that he will continue to quarantine himself as recommended by doctors.

Abbott, who was vaccinated in December, has turned down calls to reinstate mask mandates as the highly contagious Delta variant increases in Texas. He tested positive for the virus without a mask the day after he appeared indoors near Dallas without a mask while speaking to a crowded room of GOP supporters, most of whom were older and unmasked.

———

TEHERAN – Iran has reported the highest number of COVID-19 deaths from the pandemic in one day, according to state media.

The official IRNA news agency said on Sunday that 684 people had died of the disease since Saturday, while more than 36,400 new cases were confirmed in the same 24-hour period.

Iran’s previous daily record for COVID-19 deaths was recorded on August 16. The country reported the highest number of daily cases the next day, exceeding 50,000.

A five-day lockdown in the country ended on Saturday.

The current wave of infections is the fifth pandemic in Iran and is fueled by the highly contagious Delta variant. The country is also struggling to vaccinate its population against the coronavirus. About 7% of Iranians are fully vaccinated.

———

WELLINGTON, New Zealand – Japan, Australia and New Zealand all weathered the first year of the coronavirus pandemic in relatively good shape, but are taking different approaches to dealing with new outbreaks of the fast-spreading Delta variant.

The discovery of a single local COVID-19 case in New Zealand was enough for the government to put the entire country under strict lockdown for the past week.

Elsewhere in the Pacific, however, in the face of a record spike, Japan is resisting such measures and instead emphasizing its accelerated vaccine program. And Australia fell somewhere in the middle.

The different approaches could have far-reaching consequences for the economies of these nations and the health of their citizens.

Professor Michael Baker, an epidemiologist at New Zealand’s University of Otago, said countries around the world are struggling to adapt to the highly contagious variant.

“The old rules just don’t work with the Delta variant,” he says.

———

NASHVILLE, Tennessee – A Conservative talk radio host from Tennessee who was a vaccine skeptic of COVID-19 until he was hospitalized has died. He was 61.

The Nashville radio station SuperTalk 99.7 WTN confirmed the death of Phil Valentine in a tweet on Saturday.

Valentine was a skeptic about coronavirus vaccines. But after testing positive for COVID-19 and before going to hospital, he told his audience to think: “If I get this COVID thing, do I have a chance of dying from it?” If so, he advised them to get vaccinated. He said he decided not to have a vaccination because he thought he was unlikely to die.

After Valentine was transferred to an intensive care unit, his brother Mark said the talk radio host regretted that “he was not a staunch advocate of vaccination.”

“I know if he could tell you that, he would tell you, ‘Go get vaccinated. Stop worrying about politics. Stop worrying about all the conspiracy theories, ”Mark Valentine told The Tennessean on July 25th.

“He regrets that he was not so persistent in getting the vaccine. Look at the Dadgum data, ”said Mark Valentine.

———

CHICAGO – Civil rights activist and two-time presidential candidate Jesse Jackson and his wife Jacqueline were hospitalized after testing positive for COVID-19, according to a statement Saturday.

Vaccinated against the coronavirus, 79-year-old Rev. Jackson received his first dose in January during a publicized event when he urged others to get the vaccination ASAP. He and his wife, 77, are being treated at Northwestern Memorial Hospital in Chicago.

“Doctors are currently monitoring the condition of both of them,” said a statement from Jesse Jackson’s nonprofit Rainbow / PUSH Coalition.

“At this point there are no further updates,” says the message. “We will provide updates as soon as they are available.”

As a protégé of the Rev. Martin Luther King, Jackson was instrumental in leading the modern civil rights movement on numerous issues, including voting rights.

Despite being diagnosed with Parkinson’s disease, he has remained active campaigning for COVID-19 vaccines for blacks who lag behind whites in the United States’ vaccination campaign.

———

FRANKFORT, Kentucky – The governor of Kentucky’s efforts to fight COVID-19 have suffered a breakthrough legal defeat.

The state’s Supreme Court on Saturday cleared the way for laws that restrict its emergency powers to come into effect. The state’s Supreme Court ordered a lower court to overturn an injunction blocking new Republican-backed laws restricting the emergency powers of Democratic Governor Andy Beshear.

The ruling revolves around a dispute between Beshear and the GOP-led legislature over the extent of the governor’s executive power in emergencies. It comes as COVID-19 cases and hospitalizations in Kentucky increase.

The governor lifted most of his pandemic restrictions in June. However, as COVID-19 cases increased due to the Delta variant, he recently signed an executive order mandating inner masks in K-12 schools, childcare and pre-kindergarten programs across Kentucky.

One of the controversial laws limits the governor’s executive orders to 30 days in emergencies, unless extended by lawmakers.

———

PARIS – Thousands of protesters marched again in cities and towns across France against a COVID-19 health passport, which is required to enter restaurants and cafes, cultural and sports venues.

For the sixth Saturday in a row, opponents denounced what they see as a restriction of their freedom. Many have criticized the measure, claiming that the French government had implicitly prescribed vaccines.

In Paris, four demonstrations were organized by different groups. Over 200 protests took place elsewhere in the country.

Despite the protests, polls have shown that the majority of French support the health passport. More than 40.5 million people in France or 60% are fully vaccinated.

France has been registering a high number of infections since last month – around 22,000 daily.

]]>
https://usay7.net/the-latest-schools-in-the-capital-of-florida-require-masks-companies/feed/ 0
Former phlebotomist risks opening Black Brew Bros. Coffee https://usay7.net/former-phlebotomist-risks-opening-black-brew-bros-coffee/ https://usay7.net/former-phlebotomist-risks-opening-black-brew-bros-coffee/#respond Sun, 22 Aug 2021 12:00:00 +0000 https://usay7.net/former-phlebotomist-risks-opening-black-brew-bros-coffee/ MINNEOLA, Florida. – Brandon Erving was working in the medical field as a phlebotomist when he realized he wanted to get into the coffee industry. “When we work in the health sector, a lot of us actually drink coffee – a lot of it – just to stay awake and focus,” said the 35-year-old. “I […]]]>

MINNEOLA, Florida. – Brandon Erving was working in the medical field as a phlebotomist when he realized he wanted to get into the coffee industry.

“When we work in the health sector, a lot of us actually drink coffee – a lot of it – just to stay awake and focus,” said the 35-year-old. “I basically learned coffee beans; the types of coffee beans, the different types. “

After learning all the specifics about the business, he started Black Brew Bros. Coffee in September 2020. The online coffee business is operated from Minneola, according to its website.

“It was difficult,” said Erving. “It was quite a challenge.”

A challenge, not only because he wanted to try his luck in the midst of a global pandemic, but he also had to learn all about marketing, promoting and branding his product on social media.

“I’m the type of person I have an idea with, I research it six months a year, find the name, write it down … I just did it,” said the native Miamier. “The COVID brought a lot of challenges because my idea with coffee was going door to door, talking to people.”

advertisement

Since addressing potential customers in person was off the table at that time, he changed gear and got into e-commerce. Erving said after researching the different types of coffee beans, he decided to sell the best quality beans.

“I don’t mix my bean. It’s 100 percent arabica, there is no blend at all, so you actually get a class A cup of coffee compared to something that has more caffeine in it, but you have to put creamer and sugar in it, ”he said. “We roast about 100 pounds of beans a day. And as soon as the orders are placed, the bag goes out within 24 hours. “

Black Brew Bros. coffee (WKMG 2021)

He says his mission is to help others too, and decided to give five percent of the profits back to those who grow the coffee beans from the regions he buys the beans from.

Brandon, who has since quit his job as a phlebotomist, said his breed inspired the name of his company.

“The name Black Brew Bros. came about as another term for coffee black brew. The name happened to match my breed as a black. As a baking entrepreneur, ”he said. “I’m interested in coffee and coffee education. I hope to inspire and promote entrepreneurship within the black community by setting an example of risking something that I am passionate about. “

advertisement

And he hopes others in his community will take a risk whatever their passion.

“I took the risk and decided I didn’t want the traditional 9-5 job. I want the black community to know that investing in yourself is the best investment and I would like to see more black entrepreneurs in the community. “

To learn more about the company, visit: https://www.blackbrewbros.com/

Copyright 2021 by WKMG ClickOrlando – All rights reserved.

]]>
https://usay7.net/former-phlebotomist-risks-opening-black-brew-bros-coffee/feed/ 0
Business highlights: infrastructure, outlook for the Fed’s throttling https://usay7.net/business-highlights-infrastructure-outlook-for-the-feds-throttling/ https://usay7.net/business-highlights-infrastructure-outlook-for-the-feds-throttling/#respond Tue, 10 Aug 2021 21:32:24 +0000 https://usay7.net/business-highlights-infrastructure-outlook-for-the-feds-throttling/ ___ Big win for infrastructure bill of 1 ton: Dems, GOP come together WASHINGTON (AP) – With a robust vote after weeks of attempts, the Senate approved the bipartisan infrastructure plan worth $ 1 trillion. A rare coalition of Democrats and Republicans joined forces on Tuesday to provide a cornerstone of President Joe Biden’s agenda. […]]]>

___

Big win for infrastructure bill of 1 ton: Dems, GOP come together

WASHINGTON (AP) – With a robust vote after weeks of attempts, the Senate approved the bipartisan infrastructure plan worth $ 1 trillion. A rare coalition of Democrats and Republicans joined forces on Tuesday to provide a cornerstone of President Joe Biden’s agenda. Passage adds momentum as it is now heading for the house. The package would provide nearly $ 550 billion in new spending on roads, bridges, broadband internet, water pipes, and other public construction systems over five years. Biden said it shows that “democracy can still work”. The Senate is turning to Biden’s larger package, a $ 3.5 trillion plan, the debate that is likely to extend into the fall.

___

Bullard: Robust employment growth supports Fed cut “soon”

WASHINGTON (AP) – Last week’s labor market report showed the continued strength of the US economy and underscored the need for the Federal Reserve to curb its stimulus measures, a Fed official said Tuesday. Federal Reserve Bank of St. Louis President James Bullard said Friday’s report, which showed healthy jobs growth of 943,000 last month, means the economy is making sufficient progress to accommodate the Fed’s monthly bond purchases Reduce or throttle the amount of 120 billion US dollars. These purchases are designed to lower longer-term interest rates and stimulate the economy.

___

Tenn. Nissan plant will be closed for 2 weeks due to lack of chips

DETROIT (AP) – Nissan says its huge factory in Smyrna, Tennessee will be closed for two weeks starting Monday. The shutdown is due to a shortage of computer chips caused by a coronavirus outbreak in Malaysia. The shutdown is one of the longest at a U.S. auto plant of this size since the semiconductor shortage began late last year. The shortage has hampered auto production worldwide. Nissan said in a statement Tuesday that it had run out of chips due to a COVID-19 outbreak at a chip factory in Malaysia. Production is expected to resume on August 30th. The 6 million square foot Tennessee factory employs 6,700 people and makes six Nissan models, including the small Rogue SUV, its best-selling vehicle.

___

Facebook bans company behind Pfizer, AstraZeneca smear campaign

PROVIDENCE, RI (AP) – Facebook has removed hundreds of accounts connected to a disinformation network operating out of Russia trying to smear COVID-19 vaccines from Pfizer and AstraZeneca. The company said Tuesday that it had banned the advertising firm behind the campaign that had offered to pay social media influencers in Europe if they post their misleading content. The plan backfired when two of these influencers revealed the network. Facebook said it traced the content to a company called Fazze, which operates out of Russia. Messages solicited for comments by Faze’s parent company were not returned on Tuesday.

___

The Kansas City Southern railroad bidding war reignites

KANSAS CITY, Missouri (AP) – Canadian Pacific has jumped back into the bidding war for Kansas City Southern with an increased bid of $ 31 billion for the U.S. railroad. But the latest offer remains lower than the competing $ 33.6 billion offer from Canadian National, which Kansas City Southern accepted back in May. Still, Canadian Pacific’s new offering will give Kansas City Southern shareholders more food for thought before they vote on the CN deal on August 19th. Investors are also waiting to see if the US Surface Transportation Board approves a key portion of the CNs plans to acquire Kansas City Southern, and that decision could be made any day.

___

Stocks rise as banks, industrial companies offset the technology slide

NEW YORK (AP) – Stocks ended another jagged day on Wall Street Tuesday, mostly higher, as gains in banks and elsewhere in the market outweighed a decline in tech companies. The S&P 500 index rose 0.1% and the Dow Jones Industrial Average rose 0.5%. The Nasdaq lost 0.5%. Crude oil rose 2.7% after collapsing the previous day. Grocer Sysco rose 6.5% after posting results much better than analysts expected. Kansas City Southern rose 7.5% after Canadian Pacific raised its bid on the railroad operator, reigniting a bidding war with Canadian National. The 10-year Treasury yield rose to 1.35%.

___

Without the “right to repair”, companies lose time and money

NEW YORK (AP) – As software and other technology flow into more products, manufacturers are making these products increasingly difficult to repair, which can cost business owners time and money. Manufacturers of products ranging from smartphones to farm equipment can withhold repair tools and create software-based locks that prevent even simple updates unless they’re done by a company-authorized repair facility. This can cost independent repair shops valuable business and countless man hours to source parts. Farmers can lose thousands waiting for authorized dealers to fix faulty equipment. And consumers end up paying more for repairs – or for items to be replaced entirely.

___

Robinhood buys shareholder communications company Say

NEW YORK (AP) – Robinhood, the trading app that brought millions of new investors to the stock market, is buying a company that helps people communicate with the companies whose stocks they buy. Robinhood Markets announced Tuesday that it had agreed to buy Say Technologies for approximately $ 140 million in cash. Say helps publicly traded companies hear what questions their investors want answered and helps investors vote at company annual meetings.

___

The S&P 500 rose 4.40 points, or 0.1%, to 4,436.75. The Dow Jones Industrial Average rose 162.82 points, or 0.5%, to 35,264.67. The Nasdaq fell 72.09 points, or 0.5%, to 14,788.09 points. The Russell 2000 Smaller Business Index gained 4.55 points, or 0.2%, to 2,239.36 points.

]]>
https://usay7.net/business-highlights-infrastructure-outlook-for-the-feds-throttling/feed/ 0
Health Logic Interactive signs non-binding letter of intent with US medical device manufacturer to sell a wholly-owned operating subsidiary https://usay7.net/health-logic-interactive-signs-non-binding-letter-of-intent-with-us-medical-device-manufacturer-to-sell-a-wholly-owned-operating-subsidiary/ https://usay7.net/health-logic-interactive-signs-non-binding-letter-of-intent-with-us-medical-device-manufacturer-to-sell-a-wholly-owned-operating-subsidiary/#respond Mon, 09 Aug 2021 16:39:02 +0000 https://usay7.net/health-logic-interactive-signs-non-binding-letter-of-intent-with-us-medical-device-manufacturer-to-sell-a-wholly-owned-operating-subsidiary/ TSXV: CHIP.H CALGARY, AB, August 9, 2021 / PRNewswire / – Health Logic Interactive Inc. (“Health logic” or the “company“) (TSXV: CHIP.H) (OTCPK: CHYPF) is pleased to announce that it has signed August 1, 2021, a non-binding letter of intent to sell its wholly owned operating subsidiary My Health Logic Inc. (“My health logic“) to […]]]>

TSXV: CHIP.H

CALGARY, AB, August 9, 2021 / PRNewswire / – Health Logic Interactive Inc. (“Health logic” or the “company“) (TSXV: CHIP.H) (OTCPK: CHYPF) is pleased to announce that it has signed August 1, 2021, a non-binding letter of intent to sell its wholly owned operating subsidiary My Health Logic Inc. (“My health logic“) to Marizyme, Inc. (“Marizyme“), on Nevada Medical device company that is publicly traded in the OTCQB (the “transaction“).

The transaction is subject to close scrutiny, approval by the TSX Venture Exchange, negotiation of final documentation, and approval by the company’s shareholders. The transaction takes place on arm’s length basis and it is currently expected that consideration for all shares issued and outstanding in My Health Logic will be common stock in the capital of Marizyme.

Marizyme has a robust IP portfolio for its medical device platform technologies. Its leading technology, DuraGraft®, is currently approved by the US Food and Drug Administration (“FDA“). Durgraft is approved in 34 countries and has its first commercial sales in Europe and Asia. Marizyme intends to list on the NASDAQ Stock Market (“NASDAQ“) within the next twelve months.

The proposed terms, which may change depending on the progress of due diligence and negotiation, include:

  • The company will receive 4,600,000 shares of Marizyme in consideration for the Health Logic asset. The number of shares has been negotiated between the parties of Marizyme and Health Logic, and the price per share is a variable number that will be set in the final agreement.
  • After the transaction, Marizyme plans to raise the necessary working capital for the combined companies, from there registration and anticipated funding for a listing on the Nasdaq.
  • My Health Logic becomes a wholly owned subsidiary of Marizyme;
  • The company has the right to nominate two candidates to Marizyme’s board of directors; It is expected that Marizyme’s management will change upon completion of the transaction.
  • My Health Logic employees and consultants will continue to serve in the same capacity as they did prior to the transaction; and
  • The transaction is subject to negotiation and execution of final documentation, satisfaction of any closing conditions, and approval of the TSXV and shareholders.

The company continues to act as a public entity on the TSXV’s NEX Board and intends to pursue funding to begin its search for new assets to develop as part of the company’s portfolio. The company plans to continue its application to the TSXV for reactivation to Tier 2 of the TSXV through the NEX board of directors. Reactivation depends on finding a new acquisition target and meeting all requirements for ongoing listing on TSXV Tier 2.

The company will host a conference call to discuss the transaction in more detail. The conference call should take place on August 16, 2021, at 1:30 p.m. PST / 4:30 p.m. EST. Please dial toll-free at 1-866-248-8441 or internationally at 1-323-289-6581.

Quote from CEO, David Barthel:

“As we have demonstrated over the past eight months, the team is able to meet its milestones as we continue to achieve our initial goals in the clinical development of our lab-on-chip technology. These accomplishments have been achieved with several aroused great interest. ” potential strategic partner. Our team is excited about this transaction which, when completed, will provide My Health Logic with the resources it needs to further develop its lab-on-chip technology. Marizyme also has a very attractive medical device pipeline. which is already on an FDA path, is a US public company and is backed by a US full-service investment bank, Univest Securities. We quickly assessed this transaction and completed an initial due diligence and look forward to the prospects at hand ”.

about the company

Health Logic Interactive, through its wholly owned operating subsidiary My Health Logic, develops and markets consumer-oriented, portable point-of-care diagnostic devices that connect to patient smartphones and digital platforms for continuous care. The company plans to use its patent-pending lab-on-chip technology to deliver quick results and facilitate the transfer of that data from the diagnostic device to the patient’s smartphone. The company expects that this data collection will enable it to better assess patient risk profiles and achieve better patient outcomes. Our mission is to give people the ability to get early detection with actionable digital management for chronic kidney disease anytime, anywhere. For more information, visit us at: www.healthlogicinteractive.com

About Marizyme, Inc.

Marizyme is an integrated life science company dedicated to the procurement, development and commercialization of therapies that minimize acute mortality and costs. The company’s flagship product, DuraGraft®, is an intraoperative vascular graft storage solution that inhibits endothelial damage and improves clinical outcomes by reducing the incidence of complications associated with vein graft failure during bypass surgery. DuraGraft® Improves coronary artery bypass graft (CABG) surgical outcomes by significantly reducing serious adverse cardiac events such as repeated revascularization and myocardial infarction. DuraGraft® is approved for use in the EU and several Asian countries, but not yet for use in the United States® Platform. Krillase® is not approved for use.

Additional information on Health Logic Interactive Inc. and its disclosure documents is available on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its regulator (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Warning notices

Certain statements in this press release are “forward-looking statements”. All statements contained in this press release that are not historical facts, including, but not limited to, the execution of a definitive agreement for the transaction and its terms, the completion of the transaction and the anticipated benefits, the financing to be provided by Marizyme, the listing of the Marizyme Shares in NASDAQ, the Company’s funding sought, the Company’s reactivation to the TSXV and the Company’s strategy, plans, goals, objectives and objectives, and any statements preceded by or preceded by the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “can”, “would”, “foresee”, “estimate”, “forecast”, “forecast”, “project.” “,” Search, “” should “or similar expressions, or the negative thereof, are forward-looking statements. These statements are not historical facts, but merely represent the company’s expectations, estimates and projections of future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. As a result, actual results could differ materially from what is expressed, implied or projected in such forward-looking statements. Other factors that could cause actual results, performance or success to differ materially include the risk factors discussed in the management’s discussion and analysis for the fiscal year ended December 31, 2020, which provide investors with useful information considering their investment objectives and caution investors not to place undue reliance on forward-looking information. As a result, all forward-looking statements in this press release are limited by these cautionary statements and other warnings or factors contained herein, and no assurance can be given that actual results or developments will be realized or, even if they will materialize, those anticipated Will have consequences for the company. These forward-looking statements speak as of the date of this press release and the company undertakes no obligation to update or revise them to reflect future information, events or circumstances or otherwise, except as required by law.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/health-logic-interactive-signs-non-binding-letter-of-intent-with-us-medical-device-company-to -selling-a-wholly-owned-subsidiary-301351260.html

SOURCE Health Logic Interactive Inc.

]]>
https://usay7.net/health-logic-interactive-signs-non-binding-letter-of-intent-with-us-medical-device-manufacturer-to-sell-a-wholly-owned-operating-subsidiary/feed/ 0
Guardant Health attends the UBS Genomics 2.0 and MedTech Innovations Summit | business https://usay7.net/guardant-health-attends-the-ubs-genomics-2-0-and-medtech-innovations-summit-business/ https://usay7.net/guardant-health-attends-the-ubs-genomics-2-0-and-medtech-innovations-summit-business/#respond Fri, 06 Aug 2021 20:17:01 +0000 https://usay7.net/guardant-health-attends-the-ubs-genomics-2-0-and-medtech-innovations-summit-business/ REDWOOD CITY, Calif .– (BUSINESS WIRE) – Aug. August 2021– Guardant Health, Inc. (Nasdaq: GH), a leader in precision oncology, announced today that it will be attending the upcoming UBS Genomics 2.0 and MedTech Innovations Summit. Guardant Health management is expected to participate in a fireside chat on Tuesday, August 10 at 4:00 p.m. Pacific […]]]>

REDWOOD CITY, Calif .– (BUSINESS WIRE) – Aug. August 2021–

Guardant Health, Inc. (Nasdaq: GH), a leader in precision oncology, announced today that it will be attending the upcoming UBS Genomics 2.0 and MedTech Innovations Summit.

Guardant Health management is expected to participate in a fireside chat on Tuesday, August 10 at 4:00 p.m. Pacific Time / 7:00 p.m. Eastern Time. A live and archived webcast of the presentation can be viewed in the Investors section of the company’s website at www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping fight cancer worldwide through the use of its proprietary tests, extensive data sets and advanced analytics. Guardant Health’s oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes, and reduce healthcare costs at all stages of cancer care. Guardant Health has commercially launched the Guardant360 ®, Guardant360 CDx, Guardant360 TissueNext ™, Guardant360 Response ™, and GuardantOMNI ® tests for advanced cancer patients and Guardant Reveal ™ for early cancer patients. These tests are fueling the development of its LUNAR screening program, which aims to meet the needs of asymptomatic individuals eligible for cancer screening.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210806005507/en/

CONTACT: Investor contact:

Carrie Mendivil

investoren@guardanthealth.com Media contact:

Anna Czene

press@guardanthealth.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL ONCOLOGY

SOURCE: Guardant Health, Inc.

Copyright Business Wire 2021.

PUB: 6/8/2021 4:15 p.m. / DISC: 6/8/2021 4:16 p.m.

http://www.businesswire.com/news/home/20210806005507/en

Copyright Business Wire 2021.

]]>
https://usay7.net/guardant-health-attends-the-ubs-genomics-2-0-and-medtech-innovations-summit-business/feed/ 0
WELL Health to Present at Canaccord Genuity’s 41st Annual Growth Conference https://usay7.net/well-health-to-present-at-canaccord-genuitys-41st-annual-growth-conference/ https://usay7.net/well-health-to-present-at-canaccord-genuitys-41st-annual-growth-conference/#respond Fri, 06 Aug 2021 11:18:04 +0000 https://usay7.net/well-health-to-present-at-canaccord-genuitys-41st-annual-growth-conference/ VANCOUVER, BC, August 6, 2021 / PRNewswire / – WELL Health Technologies Corp. (the “company” or “GOOD“) (TSXV: WELL), a company focused on consolidating and modernizing clinical and digital assets in the primary healthcare sector, is pleased to announce that it will be at 41stNS Annual Canaccord Genuity Growth Conference. Hamed Shahbazi, Chairman and Chief […]]]>

VANCOUVER, BC, August 6, 2021 / PRNewswire / – WELL Health Technologies Corp. (the “company” or “GOOD“) (TSXV: WELL), a company focused on consolidating and modernizing clinical and digital assets in the primary healthcare sector, is pleased to announce that it will be at 41stNS Annual Canaccord Genuity Growth Conference.

Hamed Shahbazi, Chairman and Chief Executive Officer of WELL, is expected to be on Wednesday 11th AugustNS at 4:30 p.m. EST (1:30 p.m. PST) in track 12. Mr. Shahbazi will discuss WELL’s revenue growth plan, short and long term expansion plans and the company’s recent acquisitions. Management will also attend one-on-one meetings with institutional investors.

The Canaccord Genuity 41NS Annual growth conference to be held August 10NS – 12NS, is a virtual conference that gives investors access to public and private companies in various sectors. To register for the event, please contact your Canaccord Genuity representative.

About WELL

WELL is an innovative, technology-enabled healthcare company whose ultimate goal is to positively impact health outcomes through the use of technology to empower and support health professionals and their patients. WELL has developed an innovative practitioner activation platform that includes comprehensive end-to-end practice management tools, including virtual care and digital patient engagement capabilities, as well as electronic health records (EMR), revenue cycle management (RCM) and data protection services. WELL uses this platform to support healthcare practitioners both inside and outside of WELL’s own omni-channel patient service offerings. WELL owns and operates Canada’s largest network of outpatient medical clinics providing primary and specialist health services and is the provider of a leading multinational, multidisciplinary telemedicine offering. WELL is listed on the Toronto Stock Exchange under the symbol “GOODTo access the company’s Canadian telemedicine service, visit tiahealth.com and for company information visit www.well.company.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/well-health-to-present-at-canaccord-genuitys-41st-annual-growth-conference-301350076.html

SOURCE WELL Health Technologies Corp.

]]>
https://usay7.net/well-health-to-present-at-canaccord-genuitys-41st-annual-growth-conference/feed/ 0
Arch Insurance expands accident and health team with Jamie Landsman, Vice President of Product Innovation and Strategy https://usay7.net/arch-insurance-expands-accident-and-health-team-with-jamie-landsman-vice-president-of-product-innovation-and-strategy/ https://usay7.net/arch-insurance-expands-accident-and-health-team-with-jamie-landsman-vice-president-of-product-innovation-and-strategy/#respond Tue, 03 Aug 2021 19:00:00 +0000 https://usay7.net/arch-insurance-expands-accident-and-health-team-with-jamie-landsman-vice-president-of-product-innovation-and-strategy/ NEW YORK–(BUSINESS WIRE) – Arch Insurance (Arch) announced today that Jamie Landsman has joined the company as Vice President, Product Innovation and Strategy, Accident & Health (A&H). Landsman brings over 20 years of A&H experience and reports to Jim Villa, Senior Vice President, Strategy and Distribution. “Jamie brings a wealth of product, sales and innovation […]]]>

NEW YORK–(BUSINESS WIRE) – Arch Insurance (Arch) announced today that Jamie Landsman has joined the company as Vice President, Product Innovation and Strategy, Accident & Health (A&H). Landsman brings over 20 years of A&H experience and reports to Jim Villa, Senior Vice President, Strategy and Distribution.

“Jamie brings a wealth of product, sales and innovation expertise to Arch at a time of great opportunity,” said Villa. “His industry expertise in a number of roles and his proven track record in A&H will help us build on our continued success in the market.”

Landsman has a long track record in A&H. Prior to joining Arch, he held various roles at Chubb, most recently as Senior Vice President responsible for leading the Affinity Markets profit center, including A&H Insurtech partnerships and digital innovation.

“I am excited to have the opportunity to help Arch continue to expand its growing A&H portfolio. Arch Insurance has a proven leadership role in product and sales innovation, ”said Landsman. “I look forward to supporting the continued growth and success of the company.”

About Arch Insurance North America

Arch Insurance North America, part of Arch Capital Group Ltd., comprises Arch’s insurance business in the United States and Canada.

About Arch Capital Group Ltd.

Arch Capital Group Ltd., a publicly traded, Bermuda tax-exempt company with approximately $ 16.7 billion in capital as of June 30, 2021, provides insurance, reinsurance and mortgage insurance worldwide through its wholly-owned subsidiaries.

Cautionary Note Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe haven for forward-looking statements. This press release or any other written or oral statement made by or on behalf of Arch Capital Group Ltd. and its subsidiaries may contain forward-looking statements that reflect our current views with respect to future events and financial performance. All statements contained in this press release or incorporated by reference are forward-looking statements that are not historical facts.

Forward-looking statements can generally be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe” or “continue” their negation or variations or similar terminology. Forward-looking statements contain our current assessment of risks and uncertainties. Actual events and results could differ materially from those express or implied in these statements. A non-exclusive list of important factors that could cause actual results to differ materially from those shown in such forward-looking statements includes the following: adverse general economic and market conditions; increased competition; Pricing and political maturity trends; Fluctuations in the actions of rating agencies and the company’s ability to maintain and improve its ratings; Investment performance; the loss of key personnel; the adequacy of the company’s loss reserves, the severity and / or frequency of claims, claims ratios that are above expectations and the adverse development of claims and / or claims cost liabilities; greater frequency or severity of unpredictable natural and man-made disasters, including pandemics such as COVID-19; the effects of acts of terrorism and war; Changes in regulations and / or tax laws in the United States or elsewhere; the company’s ability to successfully integrate, establish and maintain operations, complete acquisitions, and integrate with existing operations the businesses that the company has acquired or may acquire; Changes in accounting policies or guidelines; material differences between actual and expected ratings for guarantee funds and mandatory pooling arrangements; The availability and cost of reinsurance to the company to manage the gross and net risks of the company; failure of others to meet their obligations to the company; Changes to the method used to determine the London Interbank Offered Rate (“LIBOR”) and the possible replacement of LIBOR and other factors identified in the Company’s filings with the US Securities and Exchange Commission.

The above review of important factors should not be considered exhaustive and should be read in conjunction with other warnings contained here or elsewhere. All subsequent written and oral forward-looking statements that are attributable to us or to persons acting on our behalf are expressly restricted in their entirety by this warning notice. The company assumes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or for any other reason.

Keyword: bow insurance

]]>
https://usay7.net/arch-insurance-expands-accident-and-health-team-with-jamie-landsman-vice-president-of-product-innovation-and-strategy/feed/ 0
Excursion Health goes to Nasdaq as Wall Street opens to the “psychedelics renaissance” https://usay7.net/excursion-health-goes-to-nasdaq-as-wall-street-opens-to-the-psychedelics-renaissance/ https://usay7.net/excursion-health-goes-to-nasdaq-as-wall-street-opens-to-the-psychedelics-renaissance/#respond Fri, 23 Jul 2021 21:15:06 +0000 https://usay7.net/excursion-health-goes-to-nasdaq-as-wall-street-opens-to-the-psychedelics-renaissance/ The excitement about psychedelics grows as the major US exchanges make room for more companies in the industry. On Friday, Field Trip Health Ltd. (TSX: FTRP) (OTCQX: FTRPF), a company developing a network of clinics for psychedelic therapies, announced the conditional approval of Nasdaq to list its shares on the stock exchange. In early June, […]]]>

The excitement about psychedelics grows as the major US exchanges make room for more companies in the industry.

On Friday, Field Trip Health Ltd. (TSX: FTRP) (OTCQX: FTRPF), a company developing a network of clinics for psychedelic therapies, announced the conditional approval of Nasdaq to list its shares on the stock exchange.

In early June, the company bought its Canadian shares from the Canadian Securities Exchange on the Toronto Stock Exchange. Following the completion of the Nasdaq uplisting, the shares listed in Canada will remain on the TSX, while the shares currently listed on the OTC market will be added to the Nasdaq.

The final approval is subject to the condition that the company meets the remaining conditions and regulatory requirements. An uplisting date has not yet been set.

Field Trip Health CEO Joseph del Moral said Field Trip’s anticipated listing on the Nasdaq is an important milestone in the company’s development as a publicly traded company.

We believe this anticipated listing will improve liquidity by allowing more investors to participate in our growth and, ultimately, increase long-term shareholder value. This is a critical time for us to increase our visibility in the market as we continue our work to build a world class and disruptive company at the forefront of the psychedelics industry, ”added de Moral.

A number of psychedelics companies are listed on Nasdaq this year, including Compass paths (NASDAQ: CMPS), MindMed (NASDAQ: MNMD), Atai life sciences (NASDAQ: ATAI) and GH research (NASDAQ: GHRS). Other companies on the exchange have started or announced to work with psychedelic molecules, such as: Seelos therapeutics (NASDAQ: SEEL) and Enveric life sciences (NASDAQ: ENVB).

On Thursday, Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF), announced similar conditional approval to listing on the NYSE.

Mujeeb Jafferi, COO. by Field Trip said: “Psychedelics are experiencing a unique renaissance, as demonstrated by the industry’s increasing support from scientists, regulators and investors alike.”

Aside from its psychedelic clinics, the company runs a drug development program using a proprietary second-generation psychedelic molecule called FT-104. The research is currently in the preclinical stage. FT-104 is believed to have psychedelic abilities with a shorter duration of action than the natural psilocybin analog.

Image by Tumisu from Pixabay.

]]>
https://usay7.net/excursion-health-goes-to-nasdaq-as-wall-street-opens-to-the-psychedelics-renaissance/feed/ 0